当前位置: X-MOL 学术RSC Med. Chem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Synthesis, molecular modeling and biological evaluation of aza-flavanones as α-glucosidase inhibitors
RSC Medicinal Chemistry ( IF 4.1 ) Pub Date : 2017-06-14 00:00:00 , DOI: 10.1039/c7md00162b
Sivaprasad Kasturi 1, 2, 3, 4, 5 , Sujatha Surarapu 1, 2, 3, 4 , Chandra Chary Bathoju 1, 2, 3, 4 , Srinivas Uppalanchi 1, 2, 3, 4 , Shubham Dwivedi 6, 7, 8, 9, 10 , Yogeeswari Perumal 6, 7, 8, 9, 10 , Dilep Kumar Sigalapalli 1, 11, 12, 13 , Bathini Nagendra Babu 1, 11, 12, 13 , Krishna S. Ethiraj 1, 2, 3, 4 , Jaya Shree Anireddy 4, 5, 14, 15
Affiliation  

An efficient acid catalyzed methodology has been employed to synthesize a variety of aza-flavanones and their α-glucosidase inhibitory activity is evaluated using acarbose, miglitol and voglibose as reference standards. Molecular modeling studies were performed for all compounds to identify the important binding modes responsible for the inhibition activity of α-glucosidase which helped find key interactions between the enzyme and the active compounds. Among all the compounds 5g, 5r and 5w have shown high α-glucosidase inhibition activity compared to standard reference drugs and have been identified as promising potential antidiabetic agents. This study is the first biological evaluation of aza-flavanones as α-glucosidase inhibitors.

中文翻译:

氮杂黄酮作为α-葡萄糖苷酶抑制剂的合成,分子建模和生物学评估

已经使用一种有效的酸催化方法来合成多种氮杂黄酮,并使用阿卡波糖,米格列醇和伏格列波糖作为参考标准评估了它们对α-葡萄糖苷酶的抑制活性。对所有化合物进行了分子建模研究,以鉴定负责α-葡萄糖苷酶抑制活性的重要结合模式,这有助于发现酶与活性化合物之间的关键相互作用。在所有化合物中,与标准参考药物相比,化合物5g5r5w表现出较高的α-葡萄糖苷酶抑制活性,并被确定为有前途的潜在抗糖尿病药。这项研究是对氮杂黄酮作为α-葡萄糖苷酶抑制剂的首次生物学评估。
更新日期:2017-08-16
down
wechat
bug